# Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis

> **NCT00037700** · PHASE2 · COMPLETED · sponsor: **Amgen**

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** anakinra
- **DRUG:** pegsunercept

## Key facts

- **NCT ID:** NCT00037700
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** —
- **Final completion:** 2002-12
- **Target enrollment:** — (—)
- **Last updated:** 2009-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00037700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00037700, "Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00037700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*